NCT02743117 - Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season | Biotech Hunter

Enrollment

301

Participants

Timeline

Start Date

May 2, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions

InfluenzaHealthy

Interventions

BIOLOGICAL

Monovalent Influenza Vaccine

A single dose of 10\^(7.0 ± 0.5) FFU strain of monovalent influenza vaccine will be administered as intranasal spray on Day 1.

OTHER

Placebo

A single dose of placebo matched to monovalent influenza vaccine will be administered as intranasal spray on Day 1.

Trial Locations (3)

Research Site, Stockbridge

Research Site, South Miami

Research Site, Portland